Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1695
-0.0088 (-4.94%)
At close: Jul 31, 2026, 4:00 PM EDT
0.1670
-0.0025 (-1.47%)
After-hours: Jul 31, 2026, 7:59 PM EDT
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $82.86 million as of July 31, 2026. Its market cap has decreased by -82.47% in one year.
Market Cap
82.86M
Enterprise Value
186.58M
1-Year Change
-82.47%
Ranking
Category
Stock Price
$0.17
ChartMarket Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $82.86M, a decrease of -91.67%. That is a compound annual growth rate of -28.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 82.86M | -88.45% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 90.53M |
| Oncolytics Biotech | 89.52M |
| OKYO Pharma | 86.85M |
| Biomea Fusion | 86.04M |
| Telomir Pharmaceuticals | 85.28M |
| PolyPid | 84.94M |
| Kalaris Therapeutics | 84.46M |
| Rallybio | 84.45M |